Ex parte TAKAGI et al. - Page 5




          Appeal No. 1998-2102                                                        
          Application 08/826,039                                                      


          determined on the basis of the evidence as a whole and the                  
          relative persuasiveness of the arguments.  See In re Oetiker,               
          977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In              
          re Hedges, 783 F.2d 1038, 1039, 228 USPQ 685, 686 (Fed. Cir.                
          1986); In re Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788               
          (Fed. Cir. 1984); and In re Rinehart, 531 F.2d 1048, 1052, 189              
          USPQ 143, 147 (CCPA 1976).                                                  
               We are further guided by the precedence of our reviewing               
          court, under both 35 U.S.C. § 102 and 103, that the                         
          limitations from the disclosure are not to be imported into                 
          the claims.  In re Lundberg, 244 F.2d 543, 113 USPQ 530 (CCPA               
          1957); In re Queener, 796 F.2d 461, 230 USPQ 438 (Fed. Cir.                 
          1986).  We also note that the arguments not made separately                 
          for any individual claim or claims are considered waived.  See              
          37 CFR § 1. 192 (a) and (c).  In re Baxter Travenol Labs., 952              
          F.2d 388, 391,                                                              
          21 USPQ2d 1281, 1285 (Fed. Cir. 1991) (“It is not the function              
          of this court to examine the claims in greater detail than                  
          argued by an appellant, looking for nonobvious distinctions                 
          over the prior art.”); In re Wiechert, 370 F.2d 927, 936, 152               
          USPQ 247, 254 (CCPA 1967) (“This court has uniformly followed               
                                         -5-                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007